12.8 C
Tuesday, August 9, 2022

New Govt campaign to promote COVID-19 oral antiviral treatments

Must read

The Federal Government has launched a new advertising campaign to encourage eligible Australians to access life-saving COVID-19 oral antiviral treatments.

The new antiviral treatments are available on the Pharmaceutical Benefits Scheme (PBS) with eligibility now opened up to include more people at higher risk of severe illness from COVID‑19.

“While vaccination against COVID-19 remains the first and best defence, oral antiviral treatments offer another valuable tool in Australia’s response to COVID-19,” Minister for Health and Aged Care, Mark Butler, said.

“Weekly prescriptions have nearly tripled since the Albanese Government expanded access.

“We know these medicines can prevent at-risk people from severe COVID-19, hospitalisations and worse.”

Those who can now receive Government subsidised COVID-19 oral antiviral treatments include:

  • people aged 70 years and over
  • people 50 years and over with two risk factors
  • First Nations people 30 years and over with two risk factors, and
  • immunocompromised people 18 years and older.

The public health information campaign will encourage people who are at higher risk of developing severe illness from COVID-19 to have early discussions with their GP or nurse practitioner about whether an oral antiviral treatment suits their health needs.

“This public health campaign will be critical for letting eligible Australians know how to quickly access these life-saving COVID-19 oral antiviral treatments,” Butler said.

Advertising will appear nationally on television, radio and digital video channels, and will be adapted and translated for multicultural and First Nations audiences.

For more information on the campaign and eligibility for these treatments, click here.

- Advertisement -

Leave a Reply

Latest article

- Advertisement -
Thank you! Your subscription has been confirmed. You'll hear from us soon.
Email newsletter sign-up